Cargando…
A zero-dose synthetic baseline for the personalized analysis of [(18)F]FDG-PET: Application in Alzheimer’s disease
PURPOSE: Brain 2-Deoxy-2-[(18)F]fluoroglucose ([(18)F]FDG-PET) is widely used in the diagnostic workup of Alzheimer’s disease (AD). Current tools for uptake analysis rely on non-personalized templates, which poses a challenge as decreased glucose uptake could reflect neuronal dysfunction, or heterog...
Autores principales: | Hinge, Christian, Henriksen, Otto Mølby, Lindberg, Ulrich, Hasselbalch, Steen Gregers, Højgaard, Liselotte, Law, Ian, Andersen, Flemming Littrup, Ladefoged, Claes Nøhr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749397/ https://www.ncbi.nlm.nih.gov/pubmed/36532287 http://dx.doi.org/10.3389/fnins.2022.1053783 |
Ejemplares similares
-
Estimation of brain amyloid accumulation using deep learning in clinical [(11)C]PiB PET imaging
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2023) -
DeepDixon synthetic CT for [(18F]FET) PET/MRI attenuation correction of post-surgery glioma patients with metal implants
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2023) -
Deep Learning Based Attenuation Correction of PET/MRI in Pediatric Brain Tumor Patients: Evaluation in a Clinical Setting
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2019) -
Hybrid FDG PET/MRI vs. FDG PET and CT in patients with suspected dementia – A comparison of diagnostic yield and propagated influence on clinical diagnosis and patient management
por: Kaltoft, Nicolai Stefan, et al.
Publicado: (2019) -
Deep-learning-based attenuation correction in dynamic [(15)O]H(2)O studies using PET/MRI in healthy volunteers
por: Puig, Oriol, et al.
Publicado: (2021)